Covering IPOs, Healthcare and Technology Stocks

Andrei Zakharov

A highly collaborative investment professional and research analyst with 10+ years of international experience in equity research, treasury operations, and trading positions across multiple asset classes at leading multinational banks Citibank and Morgan Stanley, UHNWI-backed family office and European independent equity research firm. A respectable background in equity capital markets, corporate treasury, investment banking operations, equity research analysis and portfolio management.

Shoulder Innovations, Inc. (SI): Small MedTech Implant Company Gaining IPO Interest

Shoulder Innovations, Inc. (SI): MedTech Implant Company Priced Well-Below Range, Opens 4% Higher

Shoulder Innovations, Inc. (SI): Another MedTech to Test the Market, Sets Terms for July 31 IPO

Shoulder Innovations IPO Preview: Seeing Value In InSet Glenoid Technology and Disruptive Ecosystem

Shoulder Innovations, Inc. (SI): Peeking at the Prospectus of Another MedTech IPO

Equity Capital Markets

Shoulder Innovations / Equity Capital Markets

<ul>
<li>Shoulder Innovations Inc., a pure-play shoulder arthroplasty device company, is expected to IPO soon. </li>
<li>The company’s amended S-1 puts the initial price range per share at $19.00 to $21.00, implying a market cap of ~$450M at midpoint on a fully-diluted basis.  </li>
<li>I have a positive view of Shoulder Innovations IPO and see upside vs. IPO price due to the company’s superior growth profile, industry-leading gross margins and capital efficient technology.</li>
</ul>


Shoulder Innovations Inc., a pure-play shoulder arthroplasty device company, is expected to IPO soon. 
The company’s amended S-1 puts the initial price range per share at $19.00 to $21.00, implying a market cap of ~$450M at midpoint on a fully-diluted basis.  
I have a positive view of Shoulder Innovations IPO and see upside vs. IPO price due to the company’s superior growth profile, industry-leading gross margins and capital efficient technology.


Shoulder Innovations IPO (SI.US): Expect Upside Vs. IPO Price Due To Superior Growth Profile